NanoTherm™
NanoActivator®
Axumin® PET/CT Scan
PET/CT Scan
Subjects in the clinical study will undergo PET/CT scans. This scan combines two imaging techniques. A positron emission tomography (PET) scan shows physiologic (functional) changes in the body, and a computed tomography (CT) scan shows a detailed depiction of your anatomy, where tumors may reside. The two imaging techniques provide the physician with detailed information about the extent and location of your disease.
Axumin®
The PET component of the PET/CT uses Axumin®. It is an FDA-approved diagnostic imaging agent, also known as a "tracer," that may help your physician better determine the location of any prostate cancer that is present. Further information on Axumin® can be provided at your request from our Medical Liaison.